Stay updated on Ublituximab in RMS: Clinical Trial

Sign up to get notified when there's something new on the Ublituximab in RMS: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ublituximab in RMS: Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now displays the revision: v3.5.5, replacing the previous v3.5.4. This reflects a small site or template update rather than changes to the study details.
    Difference
    0.0%
    Check dated 2026-06-05T22:04:47.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    A new site revision label is shown: v3.5.4 replaces the previous v3.5.3. This indicates a platform update rather than content changes on the page.
    Difference
    0.0%
    Check dated 2026-05-15T15:16:10.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page’s UI/display revision has been updated from v3.5.2 to v3.5.3, indicating a minor release change rather than an update to the study record content.
    Difference
    0.0%
    Check dated 2026-04-24T05:53:40.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:45:20.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0. Deleted Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T06:14:02.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Added Hartung et al. 'Efficacy of Ublituximab in People with Highly Active Relapsing Multiple Sclerosis' (Neurol Ther, 2026; online ahead of print). Updated page revision to v3.4.3 (replacing v3.4.2).
    Difference
    0.1%
    Check dated 2026-03-12T03:28:50.000Z thumbnail image

Stay in the know with updates to Ublituximab in RMS: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ublituximab in RMS: Clinical Trial page.